Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas.
Journal: Molecular cancer therapeutics
Published: July 05, 2014
Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
Journal: Molecular cancer therapeutics
Published: August 31, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026